ArticleJournal of Taibah University Medical Sciences2025
Assessment of glutathione peroxidase 1 and 4 expression in oral squamous cell carcinoma patients in a tertiary care center: A comparative cross-sectional study.
Article in Journal of Taibah University Medical Sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Expression patterns of glutathione peroxidases family members during tooth development.Journal of molecular histology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Glutathione peroxidase 1 (GPX1) and GPX4 are abundant antioxidant enzymes within the cytosol in mammalian tissues. These enzymes have the capacity to scavenge free radicals, and they play roles in various cancers, especially oral squamous cell carcinoma (OSCC). Objectives: 1. To compare the expression levels of GPX1 and GPX4 among different pathological stages for OSCC primary tumors. 2. To assess the associations of GPX1 and GPX4 expression with other independent variables (age, gender, site of lesion, laterality, histopathological grades, and lymph node involvement of OSCC tumor). Methods: In total, 133 prospective OSCC tissue specimens were selected from Dow Diagnostic Research and Referral Laboratory of Dow University. Expression levels of GPX1 and GPX4 were evaluated by immunohistochemistry. Immunoreactive score (IRS) values were obtained using ImageJ software. The IRS values for GPX1 and GPX4 were compared according to the pathological stages of cancer and other independent variables. Data were statistically analyzed by using SPSS version 21 and STATA. Results: Among the 133 samples, GPX4 was present in all stages of oral cancer and high IRS values mostly corresponded to moderate to strong staining intensity. By contrast, GPX1 was not found in all stages of oral cancer, and low IRS values mostly corresponded to weak staining intensity. No relationships were found with other variables. Conclusion: GPX4 was present in all stages of oral cancer and in all tissue samples, whereas GPX1 was not found in all cases. The IRS values for GPX1 and GPX4 had significant relationships with pathological stages of oral cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.